China NT Pharma Group (01011) Publishes January 2026 Monthly Return
Bulletin Express
Feb 03
China NT Pharma Group Company Limited (01011) released its Monthly Return for the period ended 31 January 2026. The company’s total authorised share capital stood at USD 50,100, comprising 62,592,500,000 ordinary shares and 32,500,000 preference shares, both with a par value of USD 0.0000008. The aggregate authorised capital for ordinary shares was USD 50,074, and the preference shares totalled USD 26.
The total number of issued ordinary shares remained at 674,246,015, with no changes from the previous month. The company further confirmed compliance with the relevant public float requirement, specifying a 25% threshold of the total issued shares in public hands under the applicable listing rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.